Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMIC study
2022-500586-27-00Phase 4Authorised
- Sponsor
- Stavanger University Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Augmentin with Placebo (2 arms). Primary endpoints: Response to treatment of amoxicillin-clavulanate and Time to relapse. Planned start Apr 2023; status: authorised.
02
Drugs
amoxicillin + clavulanate
Beyond the preview
Go deeper on 2022-500586-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500586-27-00.